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Introduction. Danish centers reserve longer time for screening colonoscopies and allocate the most experienced endoscopists to
these cases. The objective of this study is to determine the diagnostic yield in colonoscopies for diﬀerent indications to improve
planning of colonoscopy activity and allocation of the highly skilled endoscopists. Methods. Nine hundred and ninety-nine
randomly collected patients from a prospectively maintained database were grouped in deﬁned referral indication groups. Five
groups were compared in respect of the detection rate of adenomas and cancers. Results. Two hundred and eighty-nine of 1098
colonoscopies in 999 patients showed signiﬁcant neoplastic ﬁndings, resulting in 591 adenoma resections. Eighty-ﬁve percent
were treated with a snare resection, and 15% with endoscopic mucosa resection (EMR). Positive ﬁndings in the indication
groups were (1) symptoms, 25%; (2) positive screening, 17%; (3) previous resection of adenomas, 45%; (4) previous resection of
colorectal cancer, 15%; and (5) surveillance of patients with high-risk family history of cancer, 35%. Conclusion. The majority of
adenomas found during colonoscopy can be treated with simple techniques. If individualized time slots are considered, the
adenoma follow-up colonoscopies are likely to be the most time-consuming group with more than twice the number of
adenomas detected as compared to other indications.
1. Introduction
Introduction of the National Screening Program has
increased the demand for colonoscopy capacity by approxi-
mately 25% [1]. The centers performing colonoscopies are
challenged by the increased workload as experienced in the
UK and The Netherlands [2]. This may lead to longer waiting
times for the symptomatic patients and to additional
expenses for the hospitals [3]. The need for advanced endo-
scopic procedures has increased more than correspondingly
[4]. Few dedicated physicians master those, and in the major-
ity of the Danish endoscopy units, this leads to referral for a
second therapeutic colonoscopy by EMR, ESD, or transanal
endoscopic microsurgery (TEM) for the removal of advanced
adenomas [5]. Thus, a booking strategy for a colonoscopy
based upon indications may be useful to allocate the right
patients to experienced endoscopists and/or reserve individ-
ualized time slots for patients based upon the a priori risk
of positive ﬁndings. Further, the instructions in Denmark
as well as in the UK advise the units to allocate the most
experienced endoscopists to screening colonoscopies, with-
out any supporting evidence (Danish Colorectal Cancer
Group, DCCG Guidelines, August 2014, http://dccg.dk/
retningslinjer/august2014/2014_screening.pdf, cited 2016
June) [6].
The most common indications for colonoscopies are
unexplained anemia, hematochezia, diarrhea, and a positive
screening test [7, 8]. However, the diagnostic yield depends
on the indication, with unexplained diarrhea and blood in
the stools having a high diagnostic yield [9] along with the
detection of occult blood in the stool [10, 11].
Available data regarding the prevalence, clinical features,
and signiﬁcance of a colonoscopy in the evaluation of
colorectal polyps is widely published [12, 13], but an investi-
gation of the diagnostic yield of a colonoscopy for diﬀerent
indications is needed. The objective of our study was to
investigate the adenoma and cancer detection rates stratiﬁed
by diﬀerent indications.
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2. Methods
The enrollment of 999 patients was made by random extrac-
tions from a prospectively maintained database, according to
5 deﬁned indications for referral during the period from
September 1, 2013 to June 31, 2015, from our unit. The
indications were the following: (1) symptoms, (2) positive
iFOBT screening test, (3) follow-up after earlier resection of
adenomas, (4) follow-up after segmental bowel resection for
colorectal cancer, and (5) surveillance of patients with high-
risk family history of cancer (HNPCC or FAP).
Data were crosschecked with the local regional patient
data registry and the local electronic patient ﬁles. Patients
were randomly selected from the database, from a list of
patients who were referred to a colonoscopy at the surgical
department. All indications were related to the increased risk
of colorectal adenomas and cancer. Patients referred to a
colonoscopy due to symptoms had one or more of the follow-
ing symptoms: rectal bleeding or visible blood in stools,
abdominal discomfort or changed bowel habits for more
than 2 months, unintended weight loss, or anemia. A positive
colorectal screening test was based on microscopic blood
ﬁndings in the stool obtained by the immunological FOBT
method according to Danish guidelines with a cutoﬀ value
of 100μg/L; 209 of the 251 patients were ﬁrst-time attenders
for a colonoscopy. A follow-up after treatment for benign
colorectal adenomas included only endoscopically resected
tumors. The follow-up was oﬀered to patients with high-
risk histological features, severe dysplasia, tumors larger than
10mm, or more than 3 adenomas resected at the same
colonoscopy. All the resected adenomas were judged macro-
scopically radically resected by the endoscopist and microra-
dically resected by the pathologist with a 100% agreement
level. All of the resected adenomas had a full colonoscopy
at the index colonoscopy; the time from the index colonos-
copy to the follow-up colonoscopy was minimum 12 months
for those resected by EMR and 1 year for those resected by a
simple snare technique if they were high risk and 3 years if
they were low risk. The follow-up after treatment for a
malignant tumor was oﬀered after 1 year and every third year
for patients treated with a bowel resection. Patients included
in the surveillance were diagnosed with familial adenoma-
tous polyposis, Peutz-Jeghers syndrome, and hereditary non-
polyposis colorectal cancer or had at least one ﬁrst-degree
relative diagnosed with one of these conditions. They under-
went a colonoscopy every third year. Inclusion of at least 250
colonoscopies was accomplished for all indications except for
surveillance of patients with a family history of colorectal
cancer. We were able to include 96 colonoscopies in this
group only. A total of 999 patients to achieve a minimum
of 1000 colonoscopies were enrolled; a total of 1098 colonos-
copies were enrolled (Table 1).
Each patient was registered once only and could only be
allocated to 1 indication group.
All adenomas were included regardless of size and histol-
ogy. No serrated lesions were included in this study.
General approval by the Danish Data Protection Agency
and approval by the local ethics committee of Southern
Denmark (registration number: s-20140075/2008-58-0035)
were obtained. The database is registered as a quality assess-
ment database and is therefore not registered in clinicaltrials.
gov or other freely registered databases.
3. Results
3.1. Demographics. Nine hundred and ninety-nine patients
with 1098 colonoscopies were enrolled, 497 were female,
and 601 were male, with the mean age of 64.5 and 66.7,
respectively. Of the total number of colonoscopies, 289 had
signiﬁcant neoplastic ﬁndings, resulting in 591 resected ade-
nomas, 84% of which with a simple snare technique and 16%
with EMR or ESD during a second procedure (Table 1).
3.2. Indications and Diagnostic Yield
3.2.1. Symptoms. Approximately, one fourth (25.2%,
n = 63/250) of the colonoscopies performed for symptoms
revealed one or more polyps. The total number of adenomas
Table 1
Indication group∗
1 2 3 4 5 Total
Patients enrolled 246 251 201 242 59 999
Median age (years) 63.8 (±12.9) 64.8 (±8.0) 66.7 (±8.9) 70.1 (±10.5) 52.1 (±17.7) 65.1 (±12.0)
Sex, M/F 129/121 143/108 154/96 131/120 44/52 601/497
Colonoscopies 250 251 250 251 96 1098
Positive colonoscopies (%) 63 (25.2) 42 (16.7) 113 (45.2) 37 (14.7) 34 (35.4) 289 (26.3)
Number of adenomas found∗∗ 117 107 254 63 50 591
Colonoscopies with simple snare resection (%) 47 (18.8) 38 (15.1) 103 (41.2) 29 (11.6) 30 (31.3) 247 (22.5)
Referral to advanced endoscopic resection
(EMR/ESD/TEMS)
17 (6.8) 10 (4.0) 16 (6.4) 1 (0.4) 1 (1.0) 45 (4.1)
Cancers found 2 3 0 1 1 7
∗The numerals act as synonyms for the indication groups. 1 = symptoms. 2 = positive screening for CRC cancer. 3 = surveillance after treatment of benign
polyp. 4 = surveillance after treatment of colorectal cancer. 5 = surveillance of patients with high risk of developing hereditary colorectal cancer.
∗∗Colonoscopies resulting in an uncountable number of polyps are not included. There were six colonoscopies with an uncountable number of polyps, ﬁve
cases in group 5 and 1 case in group 1.
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found was 117. The mean number of adenomas per patient
was 1.86 (n = 117/63). Forty-seven patients were treated with
a simple snare resection, 17 were referred to an advanced
local resection, and 2 cancers were detected. Four patients
(6%, n = 4/63) had a history of previous benign adenomas.
In 187/250 (74.8%) colonoscopies, no adenomas were found
(Table 2).
3.2.2. Positive Screening. Seventeen percent (n = 42/251) of
the patients having a colonoscopy preceded by a positive
screening test had adenomas, 38 of them were resected with
a snare, 10 were referred to advanced endoscopic resection,
and 3 cancers were detected (Table 2).
3.2.3. Adenoma Follow-Up. Almost half of the patients previ-
ously treated for adenomas had adenomas at follow-up (45%,
n = 113/250). Seventy-six percent were previously treated
with a simple snare resection, and 21% were treated with
EMR/ESD. There were no cancers in this group. None of
them were treated with TEM or ESD. Three percent had a
history of segmental bowel resection for a benign disease
(Table 2).
3.2.4. Cancer Follow-Up. All the patients followed after
treatment for a colorectal cancer had undergone a
segmental bowel resection. Fifteen percent had adenomas
(n = 37/251). Thirty-one were treated with a snare resec-
tion, and 3 with an advanced endoscopic resection. One
cancer was found, and 3 adenomas were left untreated
(Table 2).
3.2.5. Increased Risk of Hereditary Cancer. There were 96
patients with a history of hereditary colorectal cancer.
34 positive colonoscopies were registered; of which, 30
were treated with a simple snare resection. One was
referred to colectomy for a cancer treatment. Fifty-six per-
cent had a simple snare resection of an adenoma earlier,
and 33% of them had a new adenoma on a surveillance
colonoscopy (Table 2).
4. Discussion
Almost one third of the patients referred to the colonos-
copy had a signiﬁcant adenoma. The diagnostic yield var-
ied depending on the indication for referral. The highest
adenoma rate was seen in patients followed after an endo-
scopic resection of a benign adenoma, leading to adenoma
detection in almost half of the cases. The patients earlier
were treated for a malignant colorectal tumor, and the
screening individuals revealed the lowest frequency of ade-
nomas and cancers.
There is a variety of symptoms leading to the referral of
patients for a colonoscopy, making this group the most
inhomogeneous one in respect to the indications for a colo-
noscopy. Nevertheless, this group showed a rather high ade-
noma rate of 25%, indicating that the clinical judgement
made by a physician is a strong predictor for pathological
ﬁndings as a screening test or a surveillance colonoscopy.
Of the 250 colonoscopies in the group with symptoms, 207
were ﬁrst-time colonoscopies yielding even more polyps
where 63 colonoscopies were positive, resulting in 30% with
signiﬁcant ﬁndings. Seven had a segmental bowel resection
for causes other than cancer.
The adenoma prevalence after a positive screening test is
lower compared to other studies especially in the UK and The
Netherlands, and it is also lower than that of the Danish
National Screening Database. Our unit has a high ade-
noma detection rate compared to other national centers
(sundhed.dk, dts aarsrapport, January 2016, https://www.
sundhed.dk/sundhedsfaglig/kvalitet/kliniske-kvalitetsdatabaser/
screening/dansk-tarmkraeftscreeningsdatabase/, cited 2016
March), and the low frequency of screen-detected adenomas
in this population is most likely incidental. The adenoma
diagnostic yield of the iFOBT-positive individuals was
almost in every ﬁfth patient; the vast majority of the ade-
nomas were resected with a simple snare. The diagnostic
yield of the follow-up colonoscopy, after earlier resection
of a benign adenoma, was showed to be high. Almost
half of the patients had adenomas. Most of them were
resected with a snare, but it also revealed the highest
number of adenomas referred to advanced endoscopic
resections. Forty-four percent of patients with previous
simple snare resections had a new adenoma. Another
noteworthy point in this group is the high number of
adenomas found.
The lowest diagnostic yield seems to be after a
resection for malignancy. Only 15% of those had an
adenoma. All except 1 patient were treated with a sim-
ple snare resection, and only 1 cancer was found. One
could consider performing the follow-up colonoscopy
with larger intervals, which has already been determined
in Denmark. Another obvious explanation for the rare
ﬁndings in this group is that they have had a segment
of their bowel removed, making the probability of new
pathology smaller.
As seen in the group with a family history, the surveil-
lance colonoscopies ensure that the tumors are found in
proper time, yielding only 1 cancer and, otherwise, adenomas
managed by a simple snare resection, even though 58% of the
patients in this subgroup had adenomas and therefore a high
diagnostic yield of adenomas from a surveillance colonos-
copy. We perform 9000 colonoscopies a year in our unit. If
our expert endoscopists trained in EMR and ESD were doing
the index colonoscopy in the groups with the highest risk of
large adenomas, we could save approximately 360 patients
yearly for a second colonoscopy.
5. Conclusion
Our study indicates that patients who had an earlier endo-
scopic resection for an adenoma and patients with a family
history of hereditary colorectal cancer have the highest
diagnostic yield from surveillance colonoscopy. We found
that symptoms are strong predictors for positive ﬁndings. A
high frequency of patients was treated with a simple snare
resection. Attention should be payed to patients who had a
resection of an adenoma, because of their risk of developing
new adenomas, and a higher risk of referral to advanced
endoscopic treatment.
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